Michael Schmidt

Stock Analyst at Guggenheim

(1.18)
# 1879
Out of 5,346 analysts
148
Total ratings
51.43%
Success rate
0.84%
Average return
53 Stocks
Name Action PT Current % Upside Ratings Updated
URGN UroGen Pharma
Maintains: Buy
40 15
3.98 276.88% 1 May 23, 2025
MRSN Mersana Therapeutics
Reiterates: Buy
5 5
0.35 1328.57% 3 May 16, 2025
KYMR Kymera Therapeutics
Reiterates: Buy
52 52
30.21 72.13% 1 May 12, 2025
SWTX SpringWorks Therapeu...
Reiterates: Neutral
47 47
46.7 0.64% 3 May 12, 2025
CMPX Compass Therapeutics
Maintains: Buy
12 10
2.12 371.7% 4 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
348 350
246.47 42.01% 3 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
87 80
38.99 105.18% 3 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 10
3.06 226.8% 1 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
10.6 201.89% 3 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 16
7.5 113.33% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
4.13 93.7% 2 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 7
2.79 150.9% 4 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 109
55.32 97.04% 5 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
0.27 548.15% 3 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
7.78 79.95% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 25
8.96 179.02% 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
92 92
66.04 39.31% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
21.03 113.98% 1 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
42.56 -1.32% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 1 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
3.13 538.98% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.25 540% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 345
n/a n/a 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 31
n/a n/a 1 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 34
7.72 340.41% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 60
n/a n/a 10 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
0.72 2677.78% 3 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
170
n/a n/a 3 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
1.46 1612.33% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
4.25 605.88% 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
3.76 591.49% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 39
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 27, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 48
n/a n/a 2 Dec 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80
31.88 150.94% 4 Feb 15, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 4 Jan 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
30
n/a n/a 2 Sep 25, 2018